X

AggregoTV

Top Videos
ESMO Vision stories of Integrated Cancer Care: Verna Vanderpuye, Ghana

"I think ESMO is poised to do that and I think we have a bright future ahead of us," says ESMO member Verna Vanderpuye from Ghana.

10/23/2020
What is the Evidence that Fecal Microbiota Transplantation Can Cure GvHD?

Mette Hazenberg, Amsterdam UMC discusses evidence that fecal microbiota transplantation can cure GvHD.

12/14/2020

AggregoTV

ESMO Vision Stories of Sustainable Cancer Care: Andrea Sbrana

Is statistically significant the same as clinically significant? The ESMO-MCBS has been thought to try and answer this question even when talking about newer treatments, explains Andrea Sbrana.

12/17/2020
Colorectal Cancer and Immunotherapy with Dr. Scott Kopetz

Dr. Scott Kopetz discusses the latest breakthroughs and future promise of immunotherapy for colorectal cancer patients.

12/11/2020
Pancreatic Cancer and Immunotherapy with Dr. Elizabeth M. Jaffee

Join Dr. Elizabeth Jaffee of the Bloomberg~Kimmel Institute for Cancer Immunotherapy for a Q&A discussion about immunotherapies in clinical trials for pancreatic cancer.

12/11/2020
`
What is the Evidence that Fecal Microbiota Transplantation Can Cure GvHD?

Mette Hazenberg, Amsterdam UMC discusses evidence that fecal microbiota transplantation can cure GvHD.

12/14/2020
Leukemia, Lymphoma, Myeloma, and Immunotherapy with Dr. Philip Greenberg

Dr. Philip Greenberg discusses how immunotherapy works for blood cancers, promising immunotherapy clinical trials, as well as potential side effects.

12/11/2020

AML

How Molecular Testing Has Transformed AML Treatment Options

Dr David Sallman explains how molecular testing has transformed AML care, including a discussion of risk assessment and the role of next-generation sequencing.

09/05/2021
What Treatments Are on the Horizon for Acute Myeloid Leukemia Patients

Dr Catherine Lai shares insight about the state of FDA approvals, what is in pipeline for AML treatment, and disease monitoring technologies for improved patient care.

10/08/2021
The Importance of Induction Chemotherapy in the AML Treatment

Dr Jeffrey Lancet gives an overview of the importance of induction chemotherapy in the treatment of acute myeloid leukemia.

09/08/2021
The Role of MRD in AML

Dr Jacqueline Cloos talks on the role of measurable residual disease as a prognostic factor in the management of acute myeloid leukemia.

09/08/2021
Optimizing Transplantation Outcomes for Patients With AML

Dr Andreas Burchert outlines the latest data on the optimization of transplantation outcomes for patients with acute myeloid leukemia.

10/22/2021
New Approaches for AML Patients Who Are Not Candidates for Intensive Therapy

Dr Stéphane de Botton discusses novel treatment approached for patients with acute myeloid leukemia who are not candidates for intensive therapy.

06/27/2021

AML Video

Treatment Cessation Using Venetoclax-Based Therapy for Older Patients With AML

Dr Andrew Wei discusses the combination of venetoclax with low-dose therapy as a new standard of care for older patients with AML who have not received prior treatment...

06/28/2021
Optimizing Transplantation Outcomes for Patients With AML

Dr Andreas Burchert outlines the latest data on the optimization of transplantation outcomes for patients with acute myeloid leukemia.

10/22/2021
What Treatments Are on the Horizon for Acute Myeloid Leukemia Patients

Dr Catherine Lai shares insight about the state of FDA approvals, what is in pipeline for AML treatment, and disease monitoring technologies for improved patient care.

10/08/2021
New Approaches for AML Patients Who Are Not Candidates for Intensive Therapy

Dr Stéphane de Botton discusses novel treatment approached for patients with acute myeloid leukemia who are not candidates for intensive therapy.

06/27/2021
The Role of MRD in AML

Dr Jacqueline Cloos talks on the role of measurable residual disease as a prognostic factor in the management of acute myeloid leukemia.

09/08/2021
How Molecular Testing Has Transformed AML Treatment Options

Dr David Sallman explains how molecular testing has transformed AML care, including a discussion of risk assessment and the role of next-generation sequencing.

09/05/2021

CLL

Treatment Sequencing Options for Recurrent CLL

Dr Michael Choi discusses treatment options for patients with recurrent chronic lymphocytic leukemia.

10/25/2021
Comparing BTK and BCL-2 Inhibitor Outcomes in Different CLL Subgroups

Dr Nicole Lamanna discusses clinical evidence relating to the treatment of CLL with BTK inhibitors and BCL-2 inhibitors in older, treatment-naïve and younger patients.

09/28/2021
The Impact of COVID-19 on Immunocompromised Patients

Dr Brian Koffman and a CLL patient discusses the impact and burden of COVID on immunocompromised patients, who may not be able to mount the proper immune response to build antibodies...

11/04/2021
Clinical Trials of Fixed Duration Treatments & Novel Targets in CLL

Dr Thomas Kipps discusses data from clinical trials that have tested combinations of different types of agents, such as venetoclax and rituximab, which showed high remission...

10/29/2021
BTK Inhibitors for CLL: Acalabrutinib vs Ibrutinib

Dr Thomas Kipps discusses the use of Bruton's tyrosine kinase inhibitors, particularly acalabrutinib and ibrutinib, in the treatment of chronic lymphocytic leukemia.

10/29/2021

cSCC

Identifying Locally Advanced cSCC

Dr Axel Hauschild explains how the characteristics of disease progression may vary and the importance of closely monitoring for signs of progression.

09/21/2021
Managing Advanced CSCC With Multidisciplinary Teams

Prof Ketty Peris discusses how when treating advanced cases of cutaneous squamous cell carcinoma, evaluating all options in a multidisciplinary team setting is critical.

09/21/2021
Highlights for Skin Cancer at ESMO 2021

Dr Jason J. Luke discusses some of the highlights of skin cancer research at ESMO 2021.

09/28/2021
The Importance of Identifying High-Risk cSCC

Dr Gino In provides further context as to why it is crucial to consider the risk for recurrence or metastasis when managing advanced cSCC.

09/21/2021
Standard of Care Treatments for Patients With cMEL, cSCC, hnSCC and ACC

Dr Thomas Eigentler outlines the current first- and second-line treatment options for patients with advanced cutaneous melanoma, cutaneous squamous cell carcinoma...

10/14/2021

DLBCL

Which New Therapeutics Are Generating Excitement at This Year’s ICML?

Dr Salles summarizes preclinical data on a histone deacetylase inhibitor investigated for T-cell lymphoma, as well as data on bispecific antibodies investigated for DLBCL.

06/28/2021
Ibrutinib Plus R-CHOP for Younger Patients With DLBCL

New evidence suggests that adding the BTK inhibitor ibrutinib to a standard chemotherapy regimen may improve survival among younger people with a specific form of DLBCL.

The ASCO Post
11/05/2021
R-CHOP Dose Intensity and Survival Outcomes in DLBCL

Chan Yoon Cheah, MBBS, discusses the results of a systematic review investigating the impact of R-CHOP dose intensity on survival outcomes in patients with DLBCL.

06/02/2021
IELSG30: Treating Primary Testicular DLBCL

Dr Annarita Conconi summarizes the results of the Phase II IELSG30 trial assessing R-CHOP, intravenous methotrexate, liposomal cytarabine, and scrotal irradiation in patients with primary DLBCL of the testis.

06/30/2021
Sequencing Treatment Options in Primary Refractory DLBCL

 

Davies begins by outlining a specific patient case, caveats in the current treatment options for DLBCL, and the patterns of primary refractory DLBCL.

06/25/2021
First-in-Human Trial of ALLO-501A in R/R Large B-cell Lymphoma

Dr Michael Tees discusses the first-in-human data of ALLO-501A, an allogeneic CAR-T product under investigation in relapsed/refractory large B-cell lymphoma in the ALPHA2 study.

06/21/2021

FL

The Influence of the TME on Progression and Outcomes in Follicular Lymphoma

Dr Jessica Okosun gives an overview of current knowledge regarding the influence of the tumor microenvironment on disease progression and outcomes in follicular lymphoma.

09/29/2021
Management of Relapse Post-alloHSCT in Patients With B-Cell Lymphoma

Dr Peter Dreger discusses treatment strategies that can be used in patients with B-cell lymphomas relapsing following allogeneic hematopoietic stem cell transplantation.

10/18/2021
Satellite Symposium | Roundtable Discussion, Summary, and Conclusions

At the 16-ICML, the Lymphoma Hub hosted a virtual satellite symposium on the sequencing of therapies in high-risk relapsed/refractory lymphoma.

07/01/2021
The Relevance of Follicular Lymphoma Pathogenesis in Clinical Practice

Dr Jessica Okosun gives an overview of the molecular pathogenesis of follicular lymphoma, and its relevance in clinical practice.

09/29/2021
Efficacy and Safety of Tisagenlecleucel in Adult Patients With Relapsed/Refractory Follicular Lymphoma

Dr Stephen Schuster speaks to ecancer in an online interview for the ASCO 2021 virtual meeting about the ELARA study.

08/04/2021
2021 ESMO Review | Hematological Malignancies | Lymphoma

Dr Julie Vose from the University of Nebraska Medical Center presents a session on lymphoma treatment updates.

10/25/2021

Lung Cancer + Radiation Oncology

Updates in Radiotherapy at ELCC 2021

In this discussion, Dr Umberto Ricardi outlines the latest developments in RT for patients with lung cancer, highlighting the ability to improve treatment of brain metastases with radiosurgery...

04/12/2021
Advances in Radiation Therapy in Stage III NSCLC

Oncology specialists from a lung multidisciplinary team discuss challenges associated with radiation therapy in Stage III NSCLC.

09/07/2021
Future Perspectives on Radiation Oncology in Lung Cancer

Dr Umberto Ricardi discusses the management of patients with lung cancer who have brain metastases and the importance of precision medicine in treating these patients.

04/12/2021
Global Access to Radiotherapy for Lung Cancer

This webinar describes the current landscape and challenges to deliver RT for lung cancer, with an emphasis on low-and middle-income countries and geographically underserved regions of high-income countries.

09/22/2021
Patterns of Relapse After Radiotherapy in SCLC and Future Treatment Strategies

Dr Sanjay Popat discusses the findings of a subset analysis of the CONVERT trial investigating patterns of relapse following thoracic radiotherapy in patients with limited-stage SCLC.

04/01/2021

NSCLC

Expert Roundtable: The Management and Care of EGFR Patients

In part three of this virtual roundtable discussion, moderated by Dr Edgardo Santos, a panel of experts sat down with Oncology Learning Network to discuss the management and care of EGFR patients.<

10/28/2021
Expert Roundtable: OS Rates Among Patients With EGFR Mutations in the TKI Era

In part one of this roundtable discussion moderated by Dr Edgardo Santos, a panel of experts sat down with Oncology Learning Network to discuss the rates of OS among patients with EGFR mutations...

10/27/2021
Expert Roundtable: Overcoming Resistance in KRAS G12C-Mutated NSCLC

In part two of this roundtable discussion, Dr Melina Marmarelis, Dr Lova Sun, and Dr Hossein Borghaei, sat down with OLN to discuss overcoming resistance to KRAS G12C sensitive mutations in...

09/29/2021
Expert Roundtable: Exploring the Treatment Landscape of KRAS G12C-Mutated NSCLC

In part one of this roundtable discussion, Dr Melina Marmarelis, Dr Lova Sun, and Dr Hossein Borghaei, sat down with OLN to discuss KRAS G12C sensitive mutations in patients with lung cancer.

09/29/2021
Expert Roundtable: Biologic Differences Among EGFR/ERBB1 Mutations in Patients With Lung Cancer

In part two of this roundtable discussion, moderated by Dr Edgardo Santos, a panel of experts sat down with Oncology Learning Network to discuss the biological differences among EGFR/ERBB1 mutation

10/27/2021

Prostate

Dr Andrew Armstrong on Precision Medicine Approaches in Advanced Prostate Cancer

In this video, Dr Andrew Armstrong discusses various precision medicine approaches in advanced prostate cancer treatment.

10/22/2021
Prostate Cancer and Immunotherapy With Dr. Ana Aparicio

Dr Ana Aparicio discusses scientific and clinical research for prostate cancer treatment, as well as biomarkers and genomic sequencing, combination therapies, clinical trials, and side effects.

10/22/2021
Practice-Changing Data From ESMO 2021 in Prostate Cancer

Dr Robert Jones gives his thoughts on practice-changing data from the recent ESMO 2021 meeting.

10/14/2021
10 Warning Signs of Prostate Cancer

In its early stages, the disease rarely causes symptoms, but you may experience certain warning signs as it progresses. Here’s what to be on the lookout for.

10/15/2021
Prostate Risk Factors and Treatment

While there are several things that can increase the risk of developing prostate cancer it can also happen spontaneously, so it is very important for men to be screened.

Sickle Cell Anemia

Clinical Research and Sickle Cell Disease

This discussion explores issues in sickle cell disease clinical research from the participant's perspective.

06/17/2021
Sickle Cell Disease and COVID-19

Dr John Whyte speaks with Dr Wanda Whitten-Shurney, CEO and Medical Director of the Michigan Chapter of the SCDAA, and Clifton R. Kirkman II, a sickle cell warrior, about the impact...

09/27/2021
Sickle Cell Disease: Ask Dr Susmita Sarangi

Dr Susmita Sarangi is a pediatric hematologist/oncologist in the MedStar Georgetown University Hospital Division of Pediatric, Adolescent, and Young Adult Hematology and Oncology.

09/27/2021
Sickle Cell Disease Overview

Dr Kerry Morrone discusses what causes sickle cell disease, the signs, and symptoms and how to diagnosis it.

10/06/2021
NHS Approves 'Life Changing' Sickle Cell Disease Drug

A new treatment for sickle cell disease has been hailed as a "revolution" for sufferers. The condition is serious and lifelong and can cause severe pain and organ failure - and those who have it end up in hospital often.

10/05/2021
Spotlight
Colorectal Cancer and Immunotherapy with Dr. Scott Kopetz

Dr. Scott Kopetz discusses the latest breakthroughs and future promise of immunotherapy for colorectal cancer patients.

12/11/2020

source list reference

rgb(171, 222, 222)
#7d60d9
rgb(219, 18, 118)
#2694a4
#32a887
200, 66, 245
#85eb24
rgb(195, 2, 230)
rgb (247, 7, 79)
#352625
#4d4537
rgb(14, 133, 237)
rgb(252, 3, 223)
rgb(209, 15, 15)
rgb(115, 43, 196)
rgb(9, 151, 227)
rgb(252, 186, 3)
#d2093c
#8e3f1c
rgb(242, 0, 137)
rgb (247, 7, 79)
#76b6c3
rgb(48, 38, 189)
rgb(231, 165, 240)
rgb(230, 21, 49)
#bfcfc8
rgb (252, 186, 3)
#c61417
rgb(156, 242, 7)
rgb(91, 128, 189)
rgb(247, 139, 109)
#67e25b
#efef71
#03cffc
rgb(224, 4, 129)
#42fc9a
rgb(20, 13, 222)
rgb(84, 54, 94)
rgb(80, 147, 199)
rgb(117, 2, 247)
rgb(153, 146, 129)
#cc529a
#c59445
#c8cc0c
#bf6be3
rgb (245, 152, 2)
#e8085a
#97d1a0
#74e391
#eb6342
#b61f77
rgb(169, 196, 201)
#a153ac
rgb(5, 235, 235)
#e7f6e3
#6fc969
#9a8c2c
#a9c507
rgb(235, 190, 9)
#2b9ab3
#e61923
rgb(209, 227, 11)
#990677
#4a7bab
200, 66, 245
rgb (191, 171, 145)
#89f67c
#49a21d
rgb(126, 14, 237)
rbg(167, 124, 235)
rgb (132, 101, 173)
rgb((217, 11, 193)
#2c990a
rbg(16, 162, 230)
#d7da81
#f5ce42
rgb(217, 7, 192)
#575662
rgb (214, 104, 96)
rgb(224, 224, 4)
#a60538
rgb(2, 230, 230)
rgb(186, 130, 237)
rgb(235, 64, 52)
#49cde9
#c20fce
rgb(80,199,199)
#d95d39
#eb5834